Author

O. Onabajo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Qamra· 1 shared A. Regev· 1 shared A. Teterina· 1 shared C. M. Rosenberger· 1 shared F. Cai· 1 shared H. Shivram· 1 shared I. Rosas· 1 shared J. A. Hackney· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Qamra

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tocilizumab treatment leads to early resolution of lymphopenia and myeloid dysregulation in patients hospitalized with COVID-19

H. Shivram, J. A. Hackney, C. M. Rosenberger, A. Teterina, A. Qamra, O. Onabajo, J. McBride, F. Cai, M. Bao, L. Tsai, A. Regev, I. Rosas, R. Bauer

bioRxiv · Oct 27, 2022 · PreprintImmunology